Green Cross Corporation - Product Pipeline Review - 2016

  • ID: 3804669
  • Company Profile
  • 50 pages
  • Global Markets Direct
1 of 4
Green Cross Corporation - Product Pipeline Review - 2016

Summary

‘Green Cross Corporation - Product Pipeline Review - 2016’, provides an overview of the Green Cross Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Green Cross Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Green Cross Corporation
- The report provides overview of Green Cross Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Green Cross Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Green Cross Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Green Cross Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Green Cross Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Green Cross Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Green Cross Corporation Snapshot

Green Cross Corporation Overview

Key Information

Key Facts

Green Cross Corporation - Research and Development Overview

Key Therapeutic Areas

Green Cross Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Green Cross Corporation - Pipeline Products Glance

Green Cross Corporation - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Green Cross Corporation - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Green Cross Corporation - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Green Cross Corporation - Drug Profiles

immune globulin (human)

Product Description

Mechanism of Action

R&D Progress

antihemophilic factor (recombinant)

Product Description

Mechanism of Action

R&D Progress

GC-1107

Product Description

Mechanism of Action

R&D Progress

GC-3106A

Product Description

Mechanism of Action

R&D Progress

idursulfase beta

Product Description

Mechanism of Action

R&D Progress

margetuximab

Product Description

Mechanism of Action

R&D Progress

GC-1102

Product Description

Mechanism of Action

R&D Progress

GC-1109

Product Description

Mechanism of Action

R&D Progress

GC-1118A

Product Description

Mechanism of Action

R&D Progress

GC-3111A

Product Description

Mechanism of Action

R&D Progress

GCC-2107

Product Description

Mechanism of Action

R&D Progress

MG-1111

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugate to Target HER2 for Breast Cancer

Product Description

Mechanism of Action

R&D Progress

LCB-141XXX

Product Description

Mechanism of Action

R&D Progress

Green Cross Corporation - Pipeline Analysis

Green Cross Corporation - Pipeline Products by Target

Green Cross Corporation - Pipeline Products by Route of Administration

Green Cross Corporation - Pipeline Products by Molecule Type

Green Cross Corporation - Pipeline Products by Mechanism of Action

Green Cross Corporation - Recent Pipeline Updates

Green Cross Corporation - Dormant Projects

Green Cross Corporation - Company Statement

Green Cross Corporation - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer 50List of Tables

Green Cross Corporation, Key Information

Green Cross Corporation, Key Facts

Green Cross Corporation - Pipeline by Indication, 2016

Green Cross Corporation - Pipeline by Stage of Development, 2016

Green Cross Corporation - Monotherapy Products in Pipeline, 2016

Green Cross Corporation - Partnered Products in Pipeline, 2016

Green Cross Corporation - Partnered Products/ Combination Treatment Modalities, 2016

Green Cross Corporation - Pre-Registration, 2016

Green Cross Corporation - Phase III, 2016

Green Cross Corporation - Phase II, 2016

Green Cross Corporation - Phase I, 2016

Green Cross Corporation - Preclinical, 2016

Green Cross Corporation - Discovery, 2016

Green Cross Corporation - Pipeline by Target, 2016

Green Cross Corporation - Pipeline by Route of Administration, 2016

Green Cross Corporation - Pipeline by Molecule Type, 2016

Green Cross Corporation - Pipeline Products by Mechanism of Action, 2016

Green Cross Corporation - Recent Pipeline Updates, 2016

Green Cross Corporation - Dormant Developmental Projects,2016

Green Cross Corporation, Other Locations

Green Cross Corporation, Subsidiaries 48List of Figures

Green Cross Corporation - Pipeline by Top 10 Indication, 2016

Green Cross Corporation - Pipeline by Stage of Development, 2016

Green Cross Corporation - Monotherapy Products in Pipeline, 2016

Green Cross Corporation - Partnered Products in Pipeline, 2016

Green Cross Corporation - Pipeline by Top 10 Target, 2016

Green Cross Corporation - Pipeline by Route of Administration, 2016

Green Cross Corporation - Pipeline by Top 10 Molecule Type, 2016

Green Cross Corporation - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll